Careers Contact
Careers Contact

Investors

Since 2021, Evaxion has been listed on the Nasdaq Capital Market exchange (ticker code: EVAX). Here you can find all of the latest Evaxion investor insights: our results, upcoming events and news, important shareholder updates and much more.

Latest press releases

Email alerts
View all
Nov 7, 2025

Evaxion presents new immune data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01
Nov 6, 2025

Evaxion announces business update and third quarter 2025 financial results
Nov 3, 2025

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate

Upcoming events & presentations

View all
Nov 13 – Nov 14, 2025
|
London, United Kingdom
NextGen Omics & Data 2025
Bringing together 1000+ key scientific researchers, pharma representatives, & healthcare leaders under one roof to accelerate omics research across therapeutic areas through our NGS & Clinical Diagnostics; Multi-Omics in Single Cell and Spatial Analysis; NextGen Omics Data & Analysis; & Liquid Biopsies programmes.
Learn more

Latest events & presentations

View all
Nov 5 – Nov 9, 2025
SITC 2025
SITC 2025 provides a multidisciplinary educational and interactive environment focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. The Annual Meeting consists of cutting-edge research presentations by experts in the field, oral and poster abstract presentations and ample opportunity for structured and informal discussions, including important networking opportunities. SITC 2025 also includes updates on major national and international initiatives from academia, government and industry, as well as important society projects. Click here to learn more about the conference. 
Learn more
Q3

Latest quarterly report

View all financial reports
Presentation Presentation Webcast Webcast Transcript Transcript Press release Press release

Contact IR

Mads Kronborg
Vice President, Investor Relations & Communication
Email: mak@evaxion.ai
Telephone: +45 53 54 82 96

For general investor relations inquiries please use the contact form below

Company presentation

Stay in touch

LinkedIn
Follow Evaxion on LinkedIn to engage, connect, and stay informed.
Follow us
Twitter
Join the conversation and stay updated with Evaxion on X.
Follow us
Subscribe to email news alerts
Join our mailing list to get our latest press releases delivered straight to your inbox.
Sign up

test

test
test
test
test